Recent Updates
Recently added Catalysts
GNLX Positive Sentiment Score: 70/100

Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference

Thursday, September 7, 2023 1 min read
Key Takeaway: Genelux Corporation will present at the H.C. Wainwright 25th Annual Global Investment Conference during the week of September 11th, 2023. Thomas Zindrick, the company's President, Chairman and CEO, will provide a corporate overview to institutional investors. Additionally, Genelux will engage in virtual one-on-one meetings with interested investors, enhancing their visibility and potential for partnerships.

Market Sentiment Analysis

POSITIVE FACTORS

  • Genelux Corporation is participating in a prominent industry conference.
  • The presentation indicates active engagement with institutional investors.
  • The event provides an opportunity for potential investment discussions.

Full Press Release Details

WESTLAKE VILLAGE, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, Chairman and CEO, will present a corporate overview with institutional investors during the H.C. Wainwright 25th Annual Global Investment Conference held the week of September 11th, 2023.
The Company will also attend virtual one-on-one meetings during the conference. Institutional investors interested in arranging a meeting with Genelux management can register to attend the conference virtually or contact genelux@allelecomms.com.
About Genelux Corporation
Investor and Media Contacts
Allele Communications, LLC
genelux@allelecomms.com
Source: Genelux Corporation

Tags

Frequently Asked Questions

Who will present at the H.C. Wainwright conference?

Thomas Zindrick, President, Chairman, and CEO of Genelux Corporation.

When is the H.C. Wainwright conference scheduled?

The conference will take place the week of September 11th, 2023.

How can investors meet with Genelux management?

Investors can register virtually for the conference or email genelux@allelecomms.com.

What industry is Genelux Corporation involved in?

Genelux Corporation operates in the immuno-oncology sector.

What role does Thomas Zindrick serve at Genelux?

He serves as the President, Chairman, and CEO of the company.

Tags: GNLX Viatris Investor Conferences Healthcare Genelux Corporation H.C. Wainwright investment conference immuno-oncology
Last updated: Sep 7, 2023